Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy

Conclusions: Trisenox has novel vascular-damaging properties, preferentially against endothelium in regions of low pH or pO2, which leads to tumor cell death and enhancement of the response of tumors to radiotherapy.